ArticlePloS one2024
Explaining why increases in generic use outpace decreases in brand name medicine use in multisource markets and the role of regulation.
Katharina E Blankart et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it